nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—HTR2C—choroid plexus—systemic lupus erythematosus	0.0423	0.136	CbGeAlD
Loxapine—HTR2A—choroid plexus—systemic lupus erythematosus	0.0212	0.068	CbGeAlD
Loxapine—HTR5A—nervous system—systemic lupus erythematosus	0.00907	0.0291	CbGeAlD
Loxapine—HTR5A—central nervous system—systemic lupus erythematosus	0.00873	0.028	CbGeAlD
Loxapine—HRH4—bone marrow—systemic lupus erythematosus	0.00789	0.0253	CbGeAlD
Loxapine—HTR2A—urine—systemic lupus erythematosus	0.00567	0.0182	CbGeAlD
Loxapine—SLC6A4—blood plasma—systemic lupus erythematosus	0.0056	0.018	CbGeAlD
Loxapine—HTR7—endothelium—systemic lupus erythematosus	0.00535	0.0172	CbGeAlD
Loxapine—HTR1A—blood plasma—systemic lupus erythematosus	0.00497	0.0159	CbGeAlD
Loxapine—HTR7—blood plasma—systemic lupus erythematosus	0.00475	0.0152	CbGeAlD
Loxapine—HRH2—skin of body—systemic lupus erythematosus	0.00449	0.0144	CbGeAlD
Loxapine—CHRM5—skin of body—systemic lupus erythematosus	0.00429	0.0138	CbGeAlD
Loxapine—DRD5—lymphoid tissue—systemic lupus erythematosus	0.00387	0.0124	CbGeAlD
Loxapine—HTR1E—nervous system—systemic lupus erythematosus	0.00387	0.0124	CbGeAlD
Loxapine—HTR1E—central nervous system—systemic lupus erythematosus	0.00373	0.012	CbGeAlD
Loxapine—ADRA1B—kidney—systemic lupus erythematosus	0.00369	0.0119	CbGeAlD
Loxapine—ADRA2A—blood plasma—systemic lupus erythematosus	0.00348	0.0112	CbGeAlD
Loxapine—CHRM4—nervous system—systemic lupus erythematosus	0.00339	0.0109	CbGeAlD
Loxapine—HTR2A—endothelium—systemic lupus erythematosus	0.00333	0.0107	CbGeAlD
Loxapine—CHRM4—central nervous system—systemic lupus erythematosus	0.00327	0.0105	CbGeAlD
Loxapine—HTR1D—connective tissue—systemic lupus erythematosus	0.00317	0.0102	CbGeAlD
Loxapine—DRD3—nervous system—systemic lupus erythematosus	0.00316	0.0101	CbGeAlD
Loxapine—ADRB1—connective tissue—systemic lupus erythematosus	0.00308	0.0099	CbGeAlD
Loxapine—DRD3—central nervous system—systemic lupus erythematosus	0.00304	0.00975	CbGeAlD
Loxapine—HTR6—nervous system—systemic lupus erythematosus	0.00304	0.00975	CbGeAlD
Loxapine—HRH2—lung—systemic lupus erythematosus	0.003	0.00962	CbGeAlD
Loxapine—HTR2A—blood plasma—systemic lupus erythematosus	0.00296	0.0095	CbGeAlD
Loxapine—DRD5—nervous system—systemic lupus erythematosus	0.00296	0.00949	CbGeAlD
Loxapine—HTR6—central nervous system—systemic lupus erythematosus	0.00292	0.00938	CbGeAlD
Loxapine—DRD5—central nervous system—systemic lupus erythematosus	0.00285	0.00914	CbGeAlD
Loxapine—HRH2—nervous system—systemic lupus erythematosus	0.00278	0.00891	CbGeAlD
Loxapine—HTR1D—kidney—systemic lupus erythematosus	0.0027	0.00867	CbGeAlD
Loxapine—HRH2—central nervous system—systemic lupus erythematosus	0.00267	0.00858	CbGeAlD
Loxapine—CHRM5—nervous system—systemic lupus erythematosus	0.00265	0.00851	CbGeAlD
Loxapine—CHRM5—central nervous system—systemic lupus erythematosus	0.00255	0.0082	CbGeAlD
Loxapine—HTR7—connective tissue—systemic lupus erythematosus	0.00253	0.00811	CbGeAlD
Loxapine—ADRA1B—nervous system—systemic lupus erythematosus	0.00242	0.00778	CbGeAlD
Loxapine—HTR3A—lung—systemic lupus erythematosus	0.00236	0.00756	CbGeAlD
Loxapine—ADRA1B—central nervous system—systemic lupus erythematosus	0.00233	0.00749	CbGeAlD
Loxapine—CHRM3—kidney—systemic lupus erythematosus	0.00226	0.00725	CbGeAlD
Loxapine—DRD1—nervous system—systemic lupus erythematosus	0.00226	0.00725	CbGeAlD
Loxapine—ADRA2C—nephron tubule—systemic lupus erythematosus	0.00225	0.00722	CbGeAlD
Loxapine—HTR3A—nervous system—systemic lupus erythematosus	0.00218	0.007	CbGeAlD
Loxapine—DRD1—central nervous system—systemic lupus erythematosus	0.00218	0.00698	CbGeAlD
Loxapine—HTR7—kidney—systemic lupus erythematosus	0.00215	0.00691	CbGeAlD
Loxapine—HTR3A—central nervous system—systemic lupus erythematosus	0.0021	0.00674	CbGeAlD
Loxapine—ADRA2C—kidney—systemic lupus erythematosus	0.00198	0.00635	CbGeAlD
Loxapine—SLC6A3—lung—systemic lupus erythematosus	0.00196	0.00629	CbGeAlD
Loxapine—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.00193	0.00618	CbGeAlD
Loxapine—HRH1—connective tissue—systemic lupus erythematosus	0.00189	0.00606	CbGeAlD
Loxapine—ADRB1—lung—systemic lupus erythematosus	0.00186	0.00597	CbGeAlD
Loxapine—ADRA2A—connective tissue—systemic lupus erythematosus	0.00185	0.00595	CbGeAlD
Loxapine—HTR1B—nervous system—systemic lupus erythematosus	0.00183	0.00588	CbGeAlD
Loxapine—CHRM2—nervous system—systemic lupus erythematosus	0.00182	0.00584	CbGeAlD
Loxapine—SLC6A3—nervous system—systemic lupus erythematosus	0.00182	0.00583	CbGeAlD
Loxapine—SLC6A4—lung—systemic lupus erythematosus	0.0018	0.00577	CbGeAlD
Loxapine—CHRM1—lung—systemic lupus erythematosus	0.00179	0.00574	CbGeAlD
Loxapine—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.00178	0.00572	CbGeAlD
Loxapine—HTR1D—nervous system—systemic lupus erythematosus	0.00177	0.00569	CbGeAlD
Loxapine—HTR1B—central nervous system—systemic lupus erythematosus	0.00176	0.00566	CbGeAlD
Loxapine—HTR2C—nervous system—systemic lupus erythematosus	0.00176	0.00563	CbGeAlD
Loxapine—CHRM2—central nervous system—systemic lupus erythematosus	0.00175	0.00563	CbGeAlD
Loxapine—SLC6A3—central nervous system—systemic lupus erythematosus	0.00175	0.00561	CbGeAlD
Loxapine—HTR7—tendon—systemic lupus erythematosus	0.00174	0.00558	CbGeAlD
Loxapine—ADRB1—nervous system—systemic lupus erythematosus	0.00172	0.00553	CbGeAlD
Loxapine—HTR1D—central nervous system—systemic lupus erythematosus	0.00171	0.00548	CbGeAlD
Loxapine—HTR2C—central nervous system—systemic lupus erythematosus	0.00169	0.00542	CbGeAlD
Loxapine—SLC6A4—nervous system—systemic lupus erythematosus	0.00166	0.00534	CbGeAlD
Loxapine—ADRB1—central nervous system—systemic lupus erythematosus	0.00166	0.00532	CbGeAlD
Loxapine—CHRM1—nervous system—systemic lupus erythematosus	0.00166	0.00532	CbGeAlD
Loxapine—SLC6A4—central nervous system—systemic lupus erythematosus	0.0016	0.00514	CbGeAlD
Loxapine—ADRA2C—tendon—systemic lupus erythematosus	0.0016	0.00512	CbGeAlD
Loxapine—CHRM1—central nervous system—systemic lupus erythematosus	0.0016	0.00512	CbGeAlD
Loxapine—SLC6A2—lung—systemic lupus erythematosus	0.00158	0.00508	CbGeAlD
Loxapine—HTR2A—connective tissue—systemic lupus erythematosus	0.00158	0.00506	CbGeAlD
Loxapine—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.00154	0.00493	CbGeAlD
Loxapine—HTR7—lung—systemic lupus erythematosus	0.00152	0.00489	CbGeAlD
Loxapine—CHRM3—nervous system—systemic lupus erythematosus	0.00148	0.00476	CbGeAlD
Loxapine—HTR1A—nervous system—systemic lupus erythematosus	0.00148	0.00474	CbGeAlD
Loxapine—SLC6A2—nervous system—systemic lupus erythematosus	0.00147	0.0047	CbGeAlD
Loxapine—DRD2—lung—systemic lupus erythematosus	0.00144	0.00463	CbGeAlD
Loxapine—CHRM3—central nervous system—systemic lupus erythematosus	0.00143	0.00458	CbGeAlD
Loxapine—HTR1A—central nervous system—systemic lupus erythematosus	0.00142	0.00456	CbGeAlD
Loxapine—HTR7—nervous system—systemic lupus erythematosus	0.00141	0.00453	CbGeAlD
Loxapine—SLC6A2—central nervous system—systemic lupus erythematosus	0.00141	0.00453	CbGeAlD
Loxapine—ADRA2C—lung—systemic lupus erythematosus	0.0014	0.0045	CbGeAlD
Loxapine—ADRA1A—nervous system—systemic lupus erythematosus	0.00136	0.00437	CbGeAlD
Loxapine—HTR7—central nervous system—systemic lupus erythematosus	0.00136	0.00436	CbGeAlD
Loxapine—HTR2A—kidney—systemic lupus erythematosus	0.00134	0.00431	CbGeAlD
Loxapine—DRD2—nervous system—systemic lupus erythematosus	0.00134	0.00428	CbGeAlD
Loxapine—ADRA1A—central nervous system—systemic lupus erythematosus	0.00131	0.00421	CbGeAlD
Loxapine—ADRA2C—nervous system—systemic lupus erythematosus	0.0013	0.00416	CbGeAlD
Loxapine—HRH1—tendon—systemic lupus erythematosus	0.0013	0.00416	CbGeAlD
Loxapine—DRD2—central nervous system—systemic lupus erythematosus	0.00129	0.00412	CbGeAlD
Loxapine—ADRA2A—tendon—systemic lupus erythematosus	0.00127	0.00409	CbGeAlD
Loxapine—ADRA2C—central nervous system—systemic lupus erythematosus	0.00125	0.00401	CbGeAlD
Loxapine—HRH1—lung—systemic lupus erythematosus	0.00114	0.00365	CbGeAlD
Loxapine—ADRA2A—lung—systemic lupus erythematosus	0.00112	0.00359	CbGeAlD
Loxapine—HTR2A—tendon—systemic lupus erythematosus	0.00108	0.00348	CbGeAlD
Loxapine—HRH1—nervous system—systemic lupus erythematosus	0.00105	0.00338	CbGeAlD
Loxapine—ADRA2A—nervous system—systemic lupus erythematosus	0.00104	0.00332	CbGeAlD
Loxapine—HRH1—central nervous system—systemic lupus erythematosus	0.00102	0.00326	CbGeAlD
Loxapine—ADRA2A—central nervous system—systemic lupus erythematosus	0.000997	0.0032	CbGeAlD
Loxapine—HTR2A—lung—systemic lupus erythematosus	0.000951	0.00305	CbGeAlD
Loxapine—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.00089	0.00196	CcSEcCtD
Loxapine—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000887	0.00196	CcSEcCtD
Loxapine—Loss of consciousness—Prednisolone—systemic lupus erythematosus	0.000886	0.00196	CcSEcCtD
Loxapine—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000886	0.00195	CcSEcCtD
Loxapine—Syncope—Hydrocortisone—systemic lupus erythematosus	0.000883	0.00195	CcSEcCtD
Loxapine—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000882	0.00195	CcSEcCtD
Loxapine—HTR2A—nervous system—systemic lupus erythematosus	0.000881	0.00283	CbGeAlD
Loxapine—Angiopathy—Betamethasone—systemic lupus erythematosus	0.000877	0.00194	CcSEcCtD
Loxapine—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.000877	0.00194	CcSEcCtD
Loxapine—Convulsion—Prednisolone—systemic lupus erythematosus	0.000874	0.00193	CcSEcCtD
Loxapine—Hypertension—Prednisolone—systemic lupus erythematosus	0.000871	0.00192	CcSEcCtD
Loxapine—Shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000868	0.00192	CcSEcCtD
Loxapine—Loss of consciousness—Hydrocortisone—systemic lupus erythematosus	0.000866	0.00191	CcSEcCtD
Loxapine—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000865	0.00191	CcSEcCtD
Loxapine—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000864	0.00191	CcSEcCtD
Loxapine—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000863	0.00191	CcSEcCtD
Loxapine—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	0.000861	0.0019	CcSEcCtD
Loxapine—Alopecia—Betamethasone—systemic lupus erythematosus	0.000854	0.00188	CcSEcCtD
Loxapine—Alopecia—Dexamethasone—systemic lupus erythematosus	0.000854	0.00188	CcSEcCtD
Loxapine—Convulsion—Hydrocortisone—systemic lupus erythematosus	0.000853	0.00188	CcSEcCtD
Loxapine—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.00085	0.00188	CcSEcCtD
Loxapine—HTR2A—central nervous system—systemic lupus erythematosus	0.000848	0.00272	CbGeAlD
Loxapine—Asthenia—Leflunomide—systemic lupus erythematosus	0.000841	0.00186	CcSEcCtD
Loxapine—Syncope—Triamcinolone—systemic lupus erythematosus	0.000832	0.00184	CcSEcCtD
Loxapine—Syncope—Methylprednisolone—systemic lupus erythematosus	0.00083	0.00183	CcSEcCtD
Loxapine—Pruritus—Leflunomide—systemic lupus erythematosus	0.000829	0.00183	CcSEcCtD
Loxapine—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000824	0.00182	CcSEcCtD
Loxapine—Oedema—Prednisolone—systemic lupus erythematosus	0.000823	0.00182	CcSEcCtD
Loxapine—Dizziness—Azathioprine—systemic lupus erythematosus	0.000821	0.00181	CcSEcCtD
Loxapine—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000818	0.0018	CcSEcCtD
Loxapine—Loss of consciousness—Triamcinolone—systemic lupus erythematosus	0.000815	0.0018	CcSEcCtD
Loxapine—Loss of consciousness—Methylprednisolone—systemic lupus erythematosus	0.000813	0.00179	CcSEcCtD
Loxapine—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.000812	0.00179	CcSEcCtD
Loxapine—Shock—Prednisolone—systemic lupus erythematosus	0.00081	0.00179	CcSEcCtD
Loxapine—Cough—Triamcinolone—systemic lupus erythematosus	0.000809	0.00179	CcSEcCtD
Loxapine—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000806	0.00178	CcSEcCtD
Loxapine—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000804	0.00177	CcSEcCtD
Loxapine—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000804	0.00177	CcSEcCtD
Loxapine—Convulsion—Triamcinolone—systemic lupus erythematosus	0.000804	0.00177	CcSEcCtD
Loxapine—Tachycardia—Prednisolone—systemic lupus erythematosus	0.000803	0.00177	CcSEcCtD
Loxapine—Photosensitivity reaction—Methotrexate—systemic lupus erythematosus	0.000802	0.00177	CcSEcCtD
Loxapine—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.000802	0.00177	CcSEcCtD
Loxapine—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000801	0.00177	CcSEcCtD
Loxapine—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000799	0.00176	CcSEcCtD
Loxapine—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000798	0.00176	CcSEcCtD
Loxapine—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.000792	0.00175	CcSEcCtD
Loxapine—Shock—Hydrocortisone—systemic lupus erythematosus	0.000791	0.00174	CcSEcCtD
Loxapine—Vomiting—Azathioprine—systemic lupus erythematosus	0.000789	0.00174	CcSEcCtD
Loxapine—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000788	0.00174	CcSEcCtD
Loxapine—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000787	0.00174	CcSEcCtD
Loxapine—Tachycardia—Hydrocortisone—systemic lupus erythematosus	0.000785	0.00173	CcSEcCtD
Loxapine—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000784	0.00173	CcSEcCtD
Loxapine—Drowsiness—Methotrexate—systemic lupus erythematosus	0.000784	0.00173	CcSEcCtD
Loxapine—Rash—Azathioprine—systemic lupus erythematosus	0.000782	0.00173	CcSEcCtD
Loxapine—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000782	0.00172	CcSEcCtD
Loxapine—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000781	0.00172	CcSEcCtD
Loxapine—Fatigue—Cyclosporine—systemic lupus erythematosus	0.00078	0.00172	CcSEcCtD
Loxapine—Headache—Azathioprine—systemic lupus erythematosus	0.000777	0.00172	CcSEcCtD
Loxapine—Dizziness—Leflunomide—systemic lupus erythematosus	0.000775	0.00171	CcSEcCtD
Loxapine—Constipation—Cyclosporine—systemic lupus erythematosus	0.000773	0.00171	CcSEcCtD
Loxapine—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000772	0.0017	CcSEcCtD
Loxapine—Renal failure—Methotrexate—systemic lupus erythematosus	0.00077	0.0017	CcSEcCtD
Loxapine—Angiopathy—Prednisone—systemic lupus erythematosus	0.000764	0.00169	CcSEcCtD
Loxapine—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000762	0.00168	CcSEcCtD
Loxapine—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000762	0.00168	CcSEcCtD
Loxapine—Oedema—Triamcinolone—systemic lupus erythematosus	0.000757	0.00167	CcSEcCtD
Loxapine—Syncope—Betamethasone—systemic lupus erythematosus	0.000755	0.00167	CcSEcCtD
Loxapine—Syncope—Dexamethasone—systemic lupus erythematosus	0.000755	0.00167	CcSEcCtD
Loxapine—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000755	0.00166	CcSEcCtD
Loxapine—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000751	0.00166	CcSEcCtD
Loxapine—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000745	0.00164	CcSEcCtD
Loxapine—Vomiting—Leflunomide—systemic lupus erythematosus	0.000745	0.00164	CcSEcCtD
Loxapine—Shock—Triamcinolone—systemic lupus erythematosus	0.000745	0.00164	CcSEcCtD
Loxapine—Insomnia—Prednisolone—systemic lupus erythematosus	0.000744	0.00164	CcSEcCtD
Loxapine—Alopecia—Prednisone—systemic lupus erythematosus	0.000744	0.00164	CcSEcCtD
Loxapine—Shock—Methylprednisolone—systemic lupus erythematosus	0.000743	0.00164	CcSEcCtD
Loxapine—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000741	0.00163	CcSEcCtD
Loxapine—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.00074	0.00163	CcSEcCtD
Loxapine—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.00074	0.00163	CcSEcCtD
Loxapine—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000739	0.00163	CcSEcCtD
Loxapine—Rash—Leflunomide—systemic lupus erythematosus	0.000739	0.00163	CcSEcCtD
Loxapine—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000739	0.00163	CcSEcCtD
Loxapine—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000738	0.00163	CcSEcCtD
Loxapine—Nausea—Azathioprine—systemic lupus erythematosus	0.000737	0.00163	CcSEcCtD
Loxapine—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000737	0.00163	CcSEcCtD
Loxapine—Headache—Leflunomide—systemic lupus erythematosus	0.000734	0.00162	CcSEcCtD
Loxapine—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000731	0.00161	CcSEcCtD
Loxapine—Convulsion—Betamethasone—systemic lupus erythematosus	0.000729	0.00161	CcSEcCtD
Loxapine—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000729	0.00161	CcSEcCtD
Loxapine—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000727	0.0016	CcSEcCtD
Loxapine—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000727	0.0016	CcSEcCtD
Loxapine—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000727	0.0016	CcSEcCtD
Loxapine—Hypertension—Betamethasone—systemic lupus erythematosus	0.000727	0.0016	CcSEcCtD
Loxapine—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000722	0.00159	CcSEcCtD
Loxapine—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000706	0.00156	CcSEcCtD
Loxapine—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000704	0.00155	CcSEcCtD
Loxapine—Nausea—Leflunomide—systemic lupus erythematosus	0.000696	0.00154	CcSEcCtD
Loxapine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000694	0.00153	CcSEcCtD
Loxapine—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000693	0.00153	CcSEcCtD
Loxapine—Vision blurred—Prednisone—systemic lupus erythematosus	0.000691	0.00152	CcSEcCtD
Loxapine—Oedema—Dexamethasone—systemic lupus erythematosus	0.000687	0.00152	CcSEcCtD
Loxapine—Oedema—Betamethasone—systemic lupus erythematosus	0.000687	0.00152	CcSEcCtD
Loxapine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000685	0.00151	CcSEcCtD
Loxapine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000683	0.00151	CcSEcCtD
Loxapine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.00068	0.0015	CcSEcCtD
Loxapine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000678	0.0015	CcSEcCtD
Loxapine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000678	0.0015	CcSEcCtD
Loxapine—Shock—Betamethasone—systemic lupus erythematosus	0.000676	0.00149	CcSEcCtD
Loxapine—Shock—Dexamethasone—systemic lupus erythematosus	0.000676	0.00149	CcSEcCtD
Loxapine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000675	0.00149	CcSEcCtD
Loxapine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000674	0.00149	CcSEcCtD
Loxapine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000674	0.00149	CcSEcCtD
Loxapine—Agitation—Prednisone—systemic lupus erythematosus	0.000673	0.00149	CcSEcCtD
Loxapine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000672	0.00148	CcSEcCtD
Loxapine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000672	0.00148	CcSEcCtD
Loxapine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.00067	0.00148	CcSEcCtD
Loxapine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.00067	0.00148	CcSEcCtD
Loxapine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000666	0.00147	CcSEcCtD
Loxapine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000662	0.00146	CcSEcCtD
Loxapine—Syncope—Prednisone—systemic lupus erythematosus	0.000657	0.00145	CcSEcCtD
Loxapine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000653	0.00144	CcSEcCtD
Loxapine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000651	0.00144	CcSEcCtD
Loxapine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00065	0.00143	CcSEcCtD
Loxapine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000649	0.00143	CcSEcCtD
Loxapine—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000644	0.00142	CcSEcCtD
Loxapine—Hypotension—Betamethasone—systemic lupus erythematosus	0.000642	0.00142	CcSEcCtD
Loxapine—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000642	0.00142	CcSEcCtD
Loxapine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.00064	0.00141	CcSEcCtD
Loxapine—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000638	0.00141	CcSEcCtD
Loxapine—Convulsion—Prednisone—systemic lupus erythematosus	0.000635	0.0014	CcSEcCtD
Loxapine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000634	0.0014	CcSEcCtD
Loxapine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000633	0.0014	CcSEcCtD
Loxapine—Hypertension—Prednisone—systemic lupus erythematosus	0.000633	0.0014	CcSEcCtD
Loxapine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000624	0.00138	CcSEcCtD
Loxapine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000624	0.00138	CcSEcCtD
Loxapine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000622	0.00137	CcSEcCtD
Loxapine—Alopecia—Methotrexate—systemic lupus erythematosus	0.000622	0.00137	CcSEcCtD
Loxapine—Insomnia—Betamethasone—systemic lupus erythematosus	0.000621	0.00137	CcSEcCtD
Loxapine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000621	0.00137	CcSEcCtD
Loxapine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000617	0.00136	CcSEcCtD
Loxapine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000617	0.00136	CcSEcCtD
Loxapine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000606	0.00134	CcSEcCtD
Loxapine—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.0006	0.00132	CcSEcCtD
Loxapine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000598	0.00132	CcSEcCtD
Loxapine—Oedema—Prednisone—systemic lupus erythematosus	0.000598	0.00132	CcSEcCtD
Loxapine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000593	0.00131	CcSEcCtD
Loxapine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000593	0.00131	CcSEcCtD
Loxapine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000592	0.00131	CcSEcCtD
Loxapine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000592	0.00131	CcSEcCtD
Loxapine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000592	0.00131	CcSEcCtD
Loxapine—Shock—Prednisone—systemic lupus erythematosus	0.000588	0.0013	CcSEcCtD
Loxapine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000587	0.00129	CcSEcCtD
Loxapine—Tachycardia—Prednisone—systemic lupus erythematosus	0.000584	0.00129	CcSEcCtD
Loxapine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000583	0.00129	CcSEcCtD
Loxapine—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000577	0.00127	CcSEcCtD
Loxapine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000577	0.00127	CcSEcCtD
Loxapine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000575	0.00127	CcSEcCtD
Loxapine—Rash—Cyclosporine—systemic lupus erythematosus	0.00057	0.00126	CcSEcCtD
Loxapine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.00057	0.00126	CcSEcCtD
Loxapine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000569	0.00125	CcSEcCtD
Loxapine—Headache—Cyclosporine—systemic lupus erythematosus	0.000567	0.00125	CcSEcCtD
Loxapine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000566	0.00125	CcSEcCtD
Loxapine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000566	0.00125	CcSEcCtD
Loxapine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000561	0.00124	CcSEcCtD
Loxapine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000558	0.00123	CcSEcCtD
Loxapine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000556	0.00123	CcSEcCtD
Loxapine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000556	0.00123	CcSEcCtD
Loxapine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000556	0.00123	CcSEcCtD
Loxapine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000553	0.00122	CcSEcCtD
Loxapine—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000548	0.00121	CcSEcCtD
Loxapine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000544	0.0012	CcSEcCtD
Loxapine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000543	0.0012	CcSEcCtD
Loxapine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000542	0.0012	CcSEcCtD
Loxapine—Insomnia—Prednisone—systemic lupus erythematosus	0.000541	0.00119	CcSEcCtD
Loxapine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000537	0.00119	CcSEcCtD
Loxapine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000537	0.00118	CcSEcCtD
Loxapine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000536	0.00118	CcSEcCtD
Loxapine—Cough—Methotrexate—systemic lupus erythematosus	0.000534	0.00118	CcSEcCtD
Loxapine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000534	0.00118	CcSEcCtD
Loxapine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000532	0.00117	CcSEcCtD
Loxapine—Convulsion—Methotrexate—systemic lupus erythematosus	0.000531	0.00117	CcSEcCtD
Loxapine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000524	0.00116	CcSEcCtD
Loxapine—Chest pain—Methotrexate—systemic lupus erythematosus	0.000521	0.00115	CcSEcCtD
Loxapine—Rash—Prednisolone—systemic lupus erythematosus	0.000519	0.00115	CcSEcCtD
Loxapine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000518	0.00114	CcSEcCtD
Loxapine—Fatigue—Prednisone—systemic lupus erythematosus	0.000516	0.00114	CcSEcCtD
Loxapine—Headache—Prednisolone—systemic lupus erythematosus	0.000516	0.00114	CcSEcCtD
Loxapine—Constipation—Prednisone—systemic lupus erythematosus	0.000511	0.00113	CcSEcCtD
Loxapine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000511	0.00113	CcSEcCtD
Loxapine—Rash—Hydrocortisone—systemic lupus erythematosus	0.000507	0.00112	CcSEcCtD
Loxapine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000506	0.00112	CcSEcCtD
Loxapine—Confusional state—Methotrexate—systemic lupus erythematosus	0.000504	0.00111	CcSEcCtD
Loxapine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000504	0.00111	CcSEcCtD
Loxapine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000501	0.0011	CcSEcCtD
Loxapine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000499	0.0011	CcSEcCtD
Loxapine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000493	0.00109	CcSEcCtD
Loxapine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000493	0.00109	CcSEcCtD
Loxapine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000493	0.00109	CcSEcCtD
Loxapine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.00049	0.00108	CcSEcCtD
Loxapine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000489	0.00108	CcSEcCtD
Loxapine—Nausea—Prednisolone—systemic lupus erythematosus	0.000489	0.00108	CcSEcCtD
Loxapine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000486	0.00107	CcSEcCtD
Loxapine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000486	0.00107	CcSEcCtD
Loxapine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000481	0.00106	CcSEcCtD
Loxapine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.00048	0.00106	CcSEcCtD
Loxapine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000477	0.00105	CcSEcCtD
Loxapine—Rash—Triamcinolone—systemic lupus erythematosus	0.000477	0.00105	CcSEcCtD
Loxapine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000477	0.00105	CcSEcCtD
Loxapine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000476	0.00105	CcSEcCtD
Loxapine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000476	0.00105	CcSEcCtD
Loxapine—Headache—Triamcinolone—systemic lupus erythematosus	0.000474	0.00105	CcSEcCtD
Loxapine—Headache—Methylprednisolone—systemic lupus erythematosus	0.000473	0.00104	CcSEcCtD
Loxapine—Hypotension—Methotrexate—systemic lupus erythematosus	0.000467	0.00103	CcSEcCtD
Loxapine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000454	0.001	CcSEcCtD
Loxapine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000454	0.001	CcSEcCtD
Loxapine—Insomnia—Methotrexate—systemic lupus erythematosus	0.000452	0.000997	CcSEcCtD
Loxapine—Nausea—Triamcinolone—systemic lupus erythematosus	0.00045	0.000992	CcSEcCtD
Loxapine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000449	0.00099	CcSEcCtD
Loxapine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000449	0.00099	CcSEcCtD
Loxapine—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000446	0.000983	CcSEcCtD
Loxapine—Somnolence—Methotrexate—systemic lupus erythematosus	0.000444	0.00098	CcSEcCtD
Loxapine—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000441	0.000972	CcSEcCtD
Loxapine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000437	0.000963	CcSEcCtD
Loxapine—Vomiting—Betamethasone—systemic lupus erythematosus	0.000437	0.000963	CcSEcCtD
Loxapine—Rash—Dexamethasone—systemic lupus erythematosus	0.000433	0.000955	CcSEcCtD
Loxapine—Rash—Betamethasone—systemic lupus erythematosus	0.000433	0.000955	CcSEcCtD
Loxapine—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000433	0.000955	CcSEcCtD
Loxapine—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000433	0.000955	CcSEcCtD
Loxapine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000432	0.000952	CcSEcCtD
Loxapine—Fatigue—Methotrexate—systemic lupus erythematosus	0.000431	0.000951	CcSEcCtD
Loxapine—Headache—Dexamethasone—systemic lupus erythematosus	0.00043	0.000949	CcSEcCtD
Loxapine—Headache—Betamethasone—systemic lupus erythematosus	0.00043	0.000949	CcSEcCtD
Loxapine—Asthenia—Prednisone—systemic lupus erythematosus	0.000429	0.000947	CcSEcCtD
Loxapine—Pruritus—Prednisone—systemic lupus erythematosus	0.000423	0.000934	CcSEcCtD
Loxapine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000412	0.000909	CcSEcCtD
Loxapine—Nausea—Dexamethasone—systemic lupus erythematosus	0.000408	0.0009	CcSEcCtD
Loxapine—Nausea—Betamethasone—systemic lupus erythematosus	0.000408	0.0009	CcSEcCtD
Loxapine—Dizziness—Prednisone—systemic lupus erythematosus	0.000396	0.000873	CcSEcCtD
Loxapine—Vomiting—Prednisone—systemic lupus erythematosus	0.00038	0.000839	CcSEcCtD
Loxapine—Rash—Prednisone—systemic lupus erythematosus	0.000377	0.000832	CcSEcCtD
Loxapine—Dermatitis—Prednisone—systemic lupus erythematosus	0.000377	0.000831	CcSEcCtD
Loxapine—Headache—Prednisone—systemic lupus erythematosus	0.000375	0.000827	CcSEcCtD
Loxapine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000368	0.000813	CcSEcCtD
Loxapine—Asthenia—Methotrexate—systemic lupus erythematosus	0.000359	0.000791	CcSEcCtD
Loxapine—Nausea—Prednisone—systemic lupus erythematosus	0.000355	0.000784	CcSEcCtD
Loxapine—Pruritus—Methotrexate—systemic lupus erythematosus	0.000354	0.00078	CcSEcCtD
Loxapine—Dizziness—Methotrexate—systemic lupus erythematosus	0.000331	0.000729	CcSEcCtD
Loxapine—Vomiting—Methotrexate—systemic lupus erythematosus	0.000318	0.000701	CcSEcCtD
Loxapine—Rash—Methotrexate—systemic lupus erythematosus	0.000315	0.000695	CcSEcCtD
Loxapine—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000315	0.000695	CcSEcCtD
Loxapine—Headache—Methotrexate—systemic lupus erythematosus	0.000313	0.000691	CcSEcCtD
Loxapine—Nausea—Methotrexate—systemic lupus erythematosus	0.000297	0.000655	CcSEcCtD
Loxapine—HTR6—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.01e-05	8.55e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.01e-05	8.54e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—F2—systemic lupus erythematosus	2.01e-05	8.53e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MMP9—systemic lupus erythematosus	2e-05	8.51e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—IL6—systemic lupus erythematosus	2e-05	8.51e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.99e-05	8.48e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—ALB—systemic lupus erythematosus	1.99e-05	8.48e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	1.99e-05	8.46e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—F2—systemic lupus erythematosus	1.99e-05	8.45e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.98e-05	8.43e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	1.98e-05	8.43e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	1.97e-05	8.39e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—PTGS2—systemic lupus erythematosus	1.97e-05	8.38e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.97e-05	8.37e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	1.96e-05	8.35e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.96e-05	8.34e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.95e-05	8.31e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.95e-05	8.28e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	1.94e-05	8.25e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CD80—systemic lupus erythematosus	1.94e-05	8.23e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CD80—systemic lupus erythematosus	1.93e-05	8.21e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MMP9—systemic lupus erythematosus	1.93e-05	8.2e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	1.93e-05	8.2e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL2—systemic lupus erythematosus	1.93e-05	8.19e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CD80—systemic lupus erythematosus	1.92e-05	8.18e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.92e-05	8.17e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—IL6—systemic lupus erythematosus	1.92e-05	8.15e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—EP300—systemic lupus erythematosus	1.91e-05	8.13e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—EP300—systemic lupus erythematosus	1.91e-05	8.13e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—NOS3—systemic lupus erythematosus	1.91e-05	8.11e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CD80—systemic lupus erythematosus	1.91e-05	8.1e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MMP9—systemic lupus erythematosus	1.9e-05	8.09e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	1.9e-05	8.08e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—EP300—systemic lupus erythematosus	1.9e-05	8.07e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.9e-05	8.06e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.9e-05	8.06e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	1.89e-05	8.02e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.87e-05	7.97e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.86e-05	7.92e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—EP300—systemic lupus erythematosus	1.86e-05	7.9e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	1.85e-05	7.87e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.85e-05	7.87e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	1.84e-05	7.83e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	1.83e-05	7.8e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL2—systemic lupus erythematosus	1.83e-05	7.8e-05	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—IL6—systemic lupus erythematosus	1.83e-05	7.8e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.83e-05	7.8e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	1.83e-05	7.78e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—EP300—systemic lupus erythematosus	1.83e-05	7.78e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.83e-05	7.76e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MMP9—systemic lupus erythematosus	1.82e-05	7.75e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.82e-05	7.72e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.81e-05	7.7e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL2—systemic lupus erythematosus	1.81e-05	7.7e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.81e-05	7.7e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	1.81e-05	7.68e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EP300—systemic lupus erythematosus	1.8e-05	7.67e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.8e-05	7.67e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—IL6—systemic lupus erythematosus	1.8e-05	7.66e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	1.8e-05	7.66e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.8e-05	7.66e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.8e-05	7.65e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.79e-05	7.63e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCL2—systemic lupus erythematosus	1.79e-05	7.61e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	1.77e-05	7.54e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.77e-05	7.53e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.77e-05	7.51e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	1.77e-05	7.51e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.76e-05	7.49e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	1.75e-05	7.44e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—PTGS2—systemic lupus erythematosus	1.74e-05	7.42e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.74e-05	7.39e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.73e-05	7.37e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.73e-05	7.36e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EP300—systemic lupus erythematosus	1.73e-05	7.35e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.71e-05	7.29e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.71e-05	7.27e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.71e-05	7.26e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.69e-05	7.17e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.67e-05	7.1e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.66e-05	7.08e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.66e-05	7.07e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.66e-05	7.06e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.65e-05	7.02e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL2—systemic lupus erythematosus	1.65e-05	7.02e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EP300—systemic lupus erythematosus	1.65e-05	7e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.64e-05	6.98e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.64e-05	6.98e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	1.64e-05	6.97e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.64e-05	6.97e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.64e-05	6.96e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.63e-05	6.95e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	1.63e-05	6.95e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.63e-05	6.95e-05	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—IL6—systemic lupus erythematosus	1.63e-05	6.95e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.63e-05	6.93e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.63e-05	6.92e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EP300—systemic lupus erythematosus	1.62e-05	6.91e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TYK2—systemic lupus erythematosus	1.62e-05	6.91e-05	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—IL6—systemic lupus erythematosus	1.62e-05	6.9e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.62e-05	6.87e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.61e-05	6.86e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.61e-05	6.84e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.61e-05	6.84e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.6e-05	6.82e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.6e-05	6.82e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.6e-05	6.82e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	1.6e-05	6.8e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.6e-05	6.8e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—NOS3—systemic lupus erythematosus	1.59e-05	6.78e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.59e-05	6.76e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.58e-05	6.71e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	1.58e-05	6.71e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.57e-05	6.7e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.57e-05	6.68e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	1.57e-05	6.68e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.57e-05	6.67e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	1.56e-05	6.64e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.56e-05	6.64e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.56e-05	6.63e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.56e-05	6.63e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.56e-05	6.62e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.55e-05	6.58e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.54e-05	6.56e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.54e-05	6.54e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.54e-05	6.53e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	1.53e-05	6.49e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	1.52e-05	6.46e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	1.5e-05	6.39e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.5e-05	6.39e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	1.49e-05	6.36e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.49e-05	6.35e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.49e-05	6.34e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.49e-05	6.33e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	1.49e-05	6.32e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.48e-05	6.3e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EP300—systemic lupus erythematosus	1.48e-05	6.29e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	1.47e-05	6.24e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.46e-05	6.22e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—EP300—systemic lupus erythematosus	1.45e-05	6.17e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	1.44e-05	6.15e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.44e-05	6.12e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.43e-05	6.09e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	1.42e-05	6.05e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.42e-05	6.03e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.42e-05	6.02e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.42e-05	6.02e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.41e-05	6.01e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	1.41e-05	5.99e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.4e-05	5.96e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.39e-05	5.92e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.39e-05	5.91e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.39e-05	5.91e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.39e-05	5.89e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	1.39e-05	5.89e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.38e-05	5.87e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.38e-05	5.86e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	1.37e-05	5.83e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.37e-05	5.82e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.36e-05	5.8e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.36e-05	5.8e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL2—systemic lupus erythematosus	1.36e-05	5.78e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.36e-05	5.77e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL2—systemic lupus erythematosus	1.36e-05	5.77e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.35e-05	5.76e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL2—systemic lupus erythematosus	1.35e-05	5.75e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.35e-05	5.74e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	1.35e-05	5.73e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—IL6—systemic lupus erythematosus	1.34e-05	5.72e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.34e-05	5.7e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL2—systemic lupus erythematosus	1.34e-05	5.69e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	1.33e-05	5.68e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.33e-05	5.67e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.33e-05	5.66e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	1.33e-05	5.66e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.33e-05	5.65e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.31e-05	5.58e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.31e-05	5.56e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.3e-05	5.52e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.29e-05	5.49e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.29e-05	5.47e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.29e-05	5.47e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.29e-05	5.47e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.28e-05	5.46e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.28e-05	5.45e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.28e-05	5.44e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.28e-05	5.44e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.28e-05	5.43e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.27e-05	5.42e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.27e-05	5.42e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.27e-05	5.39e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.27e-05	5.39e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.26e-05	5.37e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.26e-05	5.37e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.26e-05	5.35e-05	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—IL6—systemic lupus erythematosus	1.25e-05	5.33e-05	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—IL6—systemic lupus erythematosus	1.25e-05	5.32e-05	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—IL6—systemic lupus erythematosus	1.24e-05	5.29e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	1.24e-05	5.29e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.24e-05	5.27e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.23e-05	5.25e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.23e-05	5.23e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.22e-05	5.21e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.22e-05	5.2e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EP300—systemic lupus erythematosus	1.22e-05	5.19e-05	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—IL6—systemic lupus erythematosus	1.22e-05	5.18e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EP300—systemic lupus erythematosus	1.22e-05	5.17e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EP300—systemic lupus erythematosus	1.21e-05	5.16e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EP300—systemic lupus erythematosus	1.2e-05	5.11e-05	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—IL6—systemic lupus erythematosus	1.2e-05	5.09e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.2e-05	5.09e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.19e-05	5.06e-05	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—IL6—systemic lupus erythematosus	1.18e-05	5.03e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.18e-05	5.01e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.17e-05	4.99e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.17e-05	4.98e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.17e-05	4.97e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.16e-05	4.93e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.16e-05	4.92e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.15e-05	4.9e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.15e-05	4.88e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.14e-05	4.84e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.13e-05	4.82e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—IL6—systemic lupus erythematosus	1.13e-05	4.81e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.11e-05	4.73e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.08e-05	4.6e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—IL6—systemic lupus erythematosus	1.08e-05	4.59e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—IL6—systemic lupus erythematosus	1.06e-05	4.53e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.06e-05	4.52e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.06e-05	4.51e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.06e-05	4.5e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.05e-05	4.48e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.05e-05	4.48e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.04e-05	4.44e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.04e-05	4.43e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—IL6—systemic lupus erythematosus	9.69e-06	4.12e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.67e-06	4.11e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	9.61e-06	4.09e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	9.27e-06	3.94e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	9.23e-06	3.92e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	8.97e-06	3.82e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	8.83e-06	3.76e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	8.14e-06	3.46e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	8.01e-06	3.41e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—IL6—systemic lupus erythematosus	7.99e-06	3.4e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—IL6—systemic lupus erythematosus	7.97e-06	3.39e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—IL6—systemic lupus erythematosus	7.94e-06	3.38e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—IL6—systemic lupus erythematosus	7.87e-06	3.35e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	7.84e-06	3.34e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	7.29e-06	3.1e-05	CbGpPWpGaD
